Jimmy Fund Press Releases
A 21-year-old patient with severe sickle cell disease is symptom-free after gene therapy knocks down BCL11A, restoring fetal hemoglobin production.
The Pan-Mass Challenge announced an unprecedented $56 million gift to Dana-Farber. The organization exceeded its fundraising goal, bringing its 39-year total to $654 million.
Dana-Farber/Brigham and Women's Cancer Center recognized as the best in the region, and among the nation’s best, for 18th consecutive yearAugust 14, 2018
Dana-Farber/Brigham and Women's Cancer Center recognized as the best in the region, and among the nation’s best, for 18th consecutive year
U.S. News & World Report has ranked Dana-Farber/Boston Children's Cancer and Blood Disorders Center the top pediatric cancer program in New England and #3 in the nation.
Dana-Farber/Brigham and Women’s Cancer Center offers CAR T-cell therapy Kymriah™, now approved for lymphomaMay 01, 2018
Dana-Farber is a certified treatment center for the just approved CAR T-cell therapy, tisagenlecleucel (Kymriah™) for certain lymphoma patients.
Researchers launched the Metastatic Prostate Cancer Project (MPC), a patient-partnered initiative that encourages men with metastatic prostate cancer across the U.S. and Canada to collaborate.